phosphorylethanolamine has been researched along with dimethyldioctadecylammonium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chierice, GO; Cuccovia, IM; Filho, OM; Luna, AC; Maria, DA; Neto, SC; Saraiva, GK | 1 |
| Chierice, GO; Hesse, H; Luna, ACL; Maria, DA; Neto, SC; Santos Filho, JRA | 1 |
2 other study(ies) available for phosphorylethanolamine and dimethyldioctadecylammonium
| Article | Year |
|---|---|
Potential antitumor activity of novel DODAC/PHO-S liposomes.
Topics: Antineoplastic Agents; Cell Cycle; Cell Proliferation; Cells, Cultured; Ethanolamines; Human Umbilical Vein Endothelial Cells; Humans; Liposomes; Neoplasms; Quaternary Ammonium Compounds; Surface-Active Agents | 2016 |
Modulation of pro-apoptotic effects and mitochondrial potential on B16F10 cells by DODAC/PHO-S liposomes.
Topics: Adjuvants, Immunologic; Animals; Apoptosis; Cell Line, Tumor; Cytotoxins; Ethanolamines; Liposomes; Melanoma, Experimental; Mice; Mitochondria; Nanotechnology; Quaternary Ammonium Compounds | 2018 |